Table 1 Baseline patient characteristics
Characteristic | Number (N = 21) | % |
|---|---|---|
Median age, years (range) | 66 (38–82) | |
Male sex | 12 | 57.1% |
ECOG performance status | ||
0 | 5 | 23.8% |
1 | 14 | 66.7% |
2 | 2 | 9.5% |
Lines of prior systemic treatment, median (range) | 3 (1–7) | |
Cancer types | ||
1. Sarcoma | 4 | 19.0% |
Angiosarcoma (scalp/nasal cavity) | 2 | 9.5% |
Pleomorphic sarcoma | 2 | 9.5% |
2. Carcinoma | 16 | 76.2% |
Atypical pituitary adenoma | 1 | 4.8% |
Primary adenocarcinoma of bladder | 1 | 4.8% |
Breast adenocarcinoma | 1 | 4.8% |
Colorectal adenocarcinoma | 5 | 23.8% |
Cholangiocarcinoma | 2 | 9.5% |
Carcinoma of unknown primary | 1 | 4.8% |
Endometrial adenocarcinoma | 1 | 4.8% |
Oesophageal squamous cell carcinoma | 1 | 4.8% |
Small intestine adenocarcinoma | 1 | 4.8% |
Thyroid carcinoma | 1 | 4.8% |
High-grade serous ovarian cancer | 1 | 4.8% |
3. Other (oligodendroglioma) | 1 | 4.8% |
